Increased frequency of late-senescent T cells lacking CD127 in chronic hepatitis C disease

European Journal of Clinical Investigation

Volumn 45, Issue 5, 2015, Pages 466-474

  Barathan, Muttiah ^a   Mohamed, Rosmawati ^a   Saeidi, Alireza ^a   Vadivelu, Jamuna ^a   Chang, Li Y ^a   Gopal, Kaliappan ^a   Ram, Mani R ^a   Ansari, Abdul W ^a   Kamarulzaman, Adeeba ^a   Velu, Vijayakumar ^b   Larsson, Marie ^c   Shankar, Esaki M ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b EMORY UNIVERSITY   (United States)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

CD38; CD57; HCV infection; IL 7R; Immunosenescence; PD 1

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; CD38 ANTIGEN; CD57 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 7 RECEPTOR; PROGRAMMED DEATH 1 RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA; PDCD1 PROTEIN, HUMAN;

AGING; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FLOW CYTOMETRY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; ADULT; CASE CONTROL STUDY; CELL AGING; CHRONIC HEPATITIS C; FEMALE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; YOUNG ADULT;

ADULT; ANTIGENS, CD27; ANTIGENS, CD28; ANTIGENS, CD38; ANTIGENS, CD57; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL AGING; FEMALE; FLOW CYTOMETRY; HEPATITIS C, CHRONIC; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PROGRAMMED CELL DEATH 1 RECEPTOR; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84928366219     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12429     Document Type: Article

References (36)

1. Saravanan S, Velu V, Kumarasamy N, Shankar EM, Nandakumar S, Murugavel KG, et al. The prevalence of hepatitis B virus and hepatitis C virus infection among patients with chronic liver disease in South India. Int J Infect Dis 2008;12:513-8.
2. Feld JJ, Liang TJ. Hepatitis C - identifying patients with progressive liver injury. Hepatology 2006;43:194-206.
3. Velu V, Saravanan S, Nandakumar S, Dhevahi E, Shankar EM, Murugavel KG, et al. Transmission of "a" determinant variants of hepatitis B virus in immunized babies born to HBsAg carrier mothers. Jpn J Infect Dis 2008;61:73-6.
4. Mangia A, Mottola L. What's new in HCV genotype 2 treatment. Liver Int 2012;32:135-40.
5. Wiegand J, Cornberg M, Aslan N, Schlaphoff V, Sarrazin C. Fate and function of hepatitis-C-virus-specific T-cells during peginterferon- α 2b therapy for acute hepatitis C. Antivir Ther 2006;12:303-16.
6. Maue AC, Yager EJ, Swain SL, Woodland DL, Blackman MA, Haynes L. T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol 2009;30:301-5.
7. Wherry EJ. T cell exhaustion. Nat Immunol 2011;131:492-9.
8. Larsson M, Shankar EM, Che KF, Saeidi A, Ellegard R, Barathan M, et al. Molecular signatures of T-cell inhibition in HIV infection. Retrovirology 2013;10:31.
9. Chou JP, Effros RB. T cell replicative senescence in human aging. Curr Pharm Des 2013;19:1680-98.
10. Dolfi DV, Mansfield KD, Polley AM, Doyle SA, Freeman GJ, Pircher H et al. Increased T-bet is associated with senescence of influenza virus-specific CD8 T cells in aged humans. J Leukoc Biol 2013;93:825-36.
11. Thimme R, Appay V, Koschella M, Panther E, Roth E, Hislop AD et al. Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J Virol 2005;79:12112-6.
12. Camous X, Pera A, Solana R, Larbi A. NK cells in healthy aging and age-associated diseases. J Biomed Biotechnol 2012;2012:Article ID 195956.
13. Seu L, Ortiz GM, Epling L, Sinclair E, Swainson LA, Bajpai UD et al. Higher CD27+ CD8+ T cells percentages during suppressive antiretroviral therapy predict greater subsequent CD4+ T cell recovery in treated HIV infection. PLoS One 2013;8:e84091.
14. Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, Crotty LE et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8 + T cells. Blood 2003;101:2711-20.
15. Fülöp T, Larbi A, Pawelec G. Human T cell aging and the impact of persistent viral infections. Front Immunol 2013;4:271.
16. Golden-Mason L, Burton JR Jr, Castelblanco N, Klarquist J, Benlloch S, Wang C et al. Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology 2006;44:1098-109.
17. Akbar AN, Henson SM. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat Rev Immunol 2011;11:289-95.
18. Molina-Pinelo S, Vallejo A, Díaz L, Soriano-Sarabia N, Ferrando-Martínez S, Resino S et al. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation. J Antimicrob Chemother 2009;64:579-88.
19. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002;8:379-85.
20. Lang PO, Govind S, Aspinall R. Reversing T cell immunosenescence: why, who, and how. Age 2013;35:609-20.
21. Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004;104:942-7.
22. Golden-Mason L, Palmer B, Klarquist J, Mengshol JA, Castelblanco N, Rosen HR. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol 2007;81:9249-58.
23. Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002;169:3447-58.
24. Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL et al. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog 2014;10:e1004078.
25. Mogensen TH, Melchjorsen J, Larsen CS, Paludan SR. Innate immune recognition and activation during HIV infection. Retrovirology 2010;7:54.
26. Petrovas C, Chaon B, Ambrozak DR, Price DA, Melenhorst JJ, Hill BJ et al. Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol 2010;183:1120-32.
27. Alcaide ML, Parmigiani A, Pallikkuth S, Roach M, Freguja R, Della Negra M et al. Immune activation in HIV-infected aging women on antiretrovirals-implications for age-associated comorbidities: a cross-sectional pilot study. PLoS One 2013;8:e63804.
28. Jurado JO, Alvarez IB, Pasquinelli V, Martínez GJ, Quiroga MF, Abbate E et al. Programmed death (PD)-1:PD-Ligand 1/PD-Ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol 2008;181:116-25.
29. + T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients. J Acquir Immune Defic Syndr 2013;64:232-40.
30. Feuth T, Arends JE, Fransen JH, Nanlohy NM, van Erpecum KJ, Siersema PD et al. Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection. PLoS One 2013;8:e59302.
31. Focosi D, Bestagno M, Burrone O, Petrini M. CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol 2010;87:107-16.
32. Palmer BE, Blyveis N, Fontenot AP, Wilson CC. Functional and phenotypic characterization of CD57+ CD4+ T cells and their association with HIV-1-induced T cell dysfunction. J Immunol 2005;175:8415-23.
33. Luciano AA, Lederman MM, Valentin-Torres A, Bazdar DA, Sieg SF. Impaired induction of CD27 and CD28 predicts naive CD4 T cell proliferation defects in HIV disease. J Immunol 2007;179:3543-9.
34. Bengsch B, Spangenberg HC, Kersting N, Neumann-Haefelin C, Panther E, von Weizsäcker F et al. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J Virol 2007;81:945-53.
35. Zhang SY, Zhang Z, Fu JL, Kang FB, Xu XS, Nie WM et al. Progressive CD127 down-regulation correlates with increased apoptosis of CD8 T cells during chronic HIV-1 infection. Eur J Immunol 2009;39:1425-34.
36. Barathan M, Gopal K, Mohamed R, Ellegard R, Saeidi A, Vadivelu V, et al. Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T-cell exhaustion and apoptosis signaling in perpheral blood mononucleocytes. Apoptosis 2015;20:466-80.